Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]astrazeneca"
Count: 4142
Selected: 0
| NCT ID | Title |
|---|
| NCT05809934 | A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | ||
| NCT01095666 | A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone | ||
| NCT00831779 | Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes | ||
| NCT00976495 | Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes | ||
| NCT01095653 | A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | ||
| NCT00683878 | Add-on to Thiazolidinedione (TZD) Failures | ||
| NCT01498185 | BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes | ||
| NCT06015737 | A Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus | ||
| NCT05999877 | PICAROS - Acalabrutinib RWE on 1L CLL in Spain | ||
| NCT05644600 | A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants. | ||
| NCT05569408 | eVusheld Assessment reaL wORld Effectiveness in DoD Health System | ||
| NCT05384262 | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects | ||
| NCT05140369 | CLL Therapy Approaches in Russia | ||
| NCT04644068 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | ||
| NCT06046534 | Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs | ||
| NCT06034743 | A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension | ||
| NCT05932641 | Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants | ||
| NCT05887011 | CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC in Routine Practices in Russia | ||
| NCT05751759 | Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment | ||
| NCT05737940 | A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 | ||
| NCT05663515 | A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs | ||
| NCT05637112 | A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice | ||
| NCT05573464 | A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease | ||
| NCT05440656 | A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab. | ||
| NCT05408039 | Tracking Treatment Pathways in Adult Patients With Hyperkalemia. | ||
| NCT05281601 | AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics | ||
| NCT05267613 | Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis | ||
| NCT04931654 | A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer | ||
| NCT04609878 | Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) | ||
| NCT04504669 | First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours | ||
| NCT04053634 | Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations | ||
| NCT03959488 | A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children | ||
| NCT03794999 | Benralizumab Pregnancy Exposure Study | ||
| NCT03519971 | Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer | ||
| NCT03330847 | To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy. | ||
| NCT03239340 | A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib | ||
| NCT03212287 | Brilinta Clinical Experience Investigation | ||
| NCT02542293 | Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) | ||
| NCT06042049 | A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab | ||
| NCT05903989 | Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND) | ||
| NCT05647122 | First in Human Study of AZD9592 in Solid Tumors | ||
| NCT05297409 | An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure | ||
| NCT05261399 | Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment | ||
| NCT05166889 | Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations | ||
| NCT05158387 | Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations. | ||
| NCT05126992 | EU Secondary Data Post-Authorisation Safety Study of AZD1222 | ||
| NCT04639219 | A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations | ||
| NCT03732677 | Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC | ||
| NCT03373045 | Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE) | ||
| NCT06040099 | A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE |
